BARRY Competitors

Stocks . Germany . 
Stock . BARRY CALLEBA ADR
BCLM Stock  EUR 12.70  0.90  7.63%   
BARRY CALLEBA ADR competes with ON SEMICONDUCTOR, SIVERS SEMICONDUCTORS, Australian Agricultural, Treasury Wine, and AGRICULTBK HADR25; as well as few others. The company operates under Consumer Defensive sector and is part of Confectioners industry. Analyzing BARRY CALLEBA competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of BARRY CALLEBA to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out BARRY CALLEBA Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of BARRY CALLEBA competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
9.4011.8014.20
Details
Intrinsic
Valuation
LowRealHigh
9.2411.6414.04
Details
Naive
Forecast
LowNextHigh
8.2810.6913.09
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
10.4011.8913.38
Details

BARRY CALLEBA Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between BARRY CALLEBA and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of BARRY and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of BARRY CALLEBA ADR does not affect the price movement of the other competitor.

High positive correlations

NUF
+ 0.7
T7W
DFA1
+ 0.55
EK7A
EK7A
+ 0.34
XS4
T7W
+ 0.26
AY5
2DG
+ 0.23
XS4
DFA1
+ 0.14
XS4
  

High negative correlations

EK7A
- 0.67
T7W
NUF
- 0.44
EK7A
DFA1
- 0.42
T7W
EK7A
- 0.42
AY5
T7W
- 0.4
XS4
DFA1
- 0.37
AY5

Risk-Adjusted Indicators

There is a big difference between BARRY Stock performing well and BARRY CALLEBA Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze BARRY CALLEBA's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

BARRY CALLEBA Competitive Analysis

The better you understand BARRY CALLEBA competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, BARRY CALLEBA's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across BARRY CALLEBA's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
BCLM XS4 2DG AY5 CTE T7W EK7A DFA1 NUF
 7.63 
 12.70 
BARRY
 3.26 
 42.11 
XS4
 3.33 
 0.31 
SIVERS
 1.28 
 0.77 
Australian
 0.00 
 0.07 
CHINA
 0.93 
 3.19 
Treasury
 0.62 
 16.10 
AGRICULTBK
 2.05 
 2.86 
DAIRY
 2.63 
 1.11 
Nufarm
Market Volatility
(90 Days Market Risk)
Not too volatile
Very steady
Out of control
Very risky
Very steady
Relatively risky
Not too volatile
Relatively risky
Very risky
Market Performance
(90 Days Performance)
Fair
Weak
Weak
Weakest
Weakest
Weakest
Mild
Weakest
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Low
High
High
High
Low
Low
Low
Low
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Hold
Hold
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Hold
Strong Sell
Cautious Hold
Current Ratio
1.82
N/A
3.67
5.37
N/A
2.55
N/A
N/A
1.8
Net Asset
N/A
11.98 B
N/A
2.05 B
645.84 M
6.66 B
N/A
7.6 B
4.66 B
Profit Margin
0.0446
N/A
-0.89
0.36
-0.85
0.1
0.44
N/A
0.0285
EBITDA
803.44 M
3.01 B
N/A
228.61 M
34.38 M
644.4 M
N/A
N/A
416.84 M
Operating Margin
0.0802
N/A
N/A
-0.7
-0.65
0.2
0.52
N/A
0.0552
Current Valuation
N/A
29.61 B
N/A
940.3 M
17.9 M
7.1 B
N/A
7.4 B
1.76 B
Price To Book
N/A
5.5
N/A
0.75
0.32
2.55
N/A
3.76
1.08
Five Year Return
N/A
N/A
N/A
N/A
N/A
2.02
N/A
N/A
1.36
Beta
0.28
N/A
0.86
-0.0857
0.14
0.44
0.43
N/A
0.5
Number Of Employees
13.42 K
N/A
130
6
351
2.5 K
455.17 K
N/A
2.81 K
Shares Outstanding
548.1 M
N/A
210.89 M
602.77 M
2.64 B
721.85 M
14 B
N/A
380.47 M
Cash Flow From Operations
763.41 M
2.63 B
N/A
24.25 M
21.7 M
562 M
(1.34 T)
N/A
359.57 M
Annual Yield
0.0138
N/A
N/A
N/A
N/A
0.0267
0.0972
0.0148
0.0214
Total Debt
2.62 B
3.05 B
N/A
375.95 M
N/A
1.51 B
2.52 T
310.8 M
539.41 M
Return On Equity
0.13
N/A
-0.18
0.083
-0.19
0.0713
0.1
N/A
0.0503
Z Score
1.8
4.8
N/A
0.6
N/A
2.4
N/A
6.6
1.2
Return On Asset
0.054
N/A
-0.11
-0.0669
-0.0793
0.0496
0.008
N/A
0.0288
Book Value Per Share
5.3
N/A
0.24
2.36
0.2
5.24
181.83
N/A
5.01
Total Asset
N/A
11.98 B
N/A
2.05 B
645.84 M
6.66 B
N/A
7.6 B
4.66 B
Debt To Equity
1.06
N/A
0.088
44.2
N/A
31.1
N/A
N/A
85.8
Last Dividend Paid
28.0
N/A
N/A
N/A
N/A
0.31
0.21
N/A
0.1
Shares Owned By Institutions
N/A
N/A
25.26
7.2
0.03
42.71
N/A
N/A
53.5
Market Capitalization
10.09 B
24.9 B
146.56 M
645.48 M
31.45 M
6.32 B
136.18 B
3.58 B
1.4 B
Price To Earnings To Growth
N/A
1.01
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Price To Earning
N/A
N/A
N/A
N/A
N/A
27.91
3.71
N/A
20.52
Price To Sales
N/A
3.99
N/A
2.31
0.85
2.41
N/A
0.43
0.39
Net Income
313.14 M
1.9 B
N/A
136.93 M
11.34 M
263.2 M
208.07 B
N/A
107.44 M
Earnings Per Share
0.66
N/A
-0.082
0.11
-0.007
0.3
2.32
N/A
0.18
Shares Owned By Insiders
N/A
N/A
31.21
73.43
51.51
0.29
N/A
N/A
6.76
Revenue
8.09 B
8.33 B
N/A
276.07 M
208.37 M
2.48 B
573.42 B
N/A
3.77 B
Cash And Equivalents
869.99 M
N/A
N/A
8.29 M
N/A
66.08 M
4.21 T
N/A
222.99 M
Cash Per Share
1.59
N/A
N/A
0.01
N/A
0.09
300.7
N/A
0.68
Gross Profit
1.22 B
N/A
116.46 M
(42.66 M)
(49.34 M)
1.07 B
555.86 B
N/A
972.59 M
Day Typical Price
12.7
42.0
0.31
0.77
0.07
3.19
16.1
2.86
1.11
Accumulation Distribution
N/A
0.0076
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Market Facilitation Index
N/A
0.32
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Daily Balance Of Power
9.2 T
4.15625
9.2 T
(9,223,372,036,855)
0.0
(9,223,372,036,855)
(9,223,372,036,855)
(9,223,372,036,855)
(9,223,372,036,855)
Period Momentum Indicator
0.9
1.33
0.01
(0.01)
N/A
(0.03)
(0.10)
(0.06)
(0.03)
Rate Of Daily Change
1.08
1.03
1.03
0.99
1.0
0.99
0.99
0.98
0.97
Day Median Price
12.7
41.95
0.31
0.77
0.07
3.19
16.1
2.86
1.11
Price Action Indicator
0.45
0.82
0.005
(0.01)
N/A
(0.01)
(0.05)
(0.03)
(0.01)
Coefficient Of Variation
1029.13
8518.78
2935.1
(5,349)
N/A
(724.25)
1055.24
(8,722)
(865.45)
Mean Deviation
1.92
2.08
3.29
1.14
N/A
1.49
1.56
1.39
1.76
Jensen Alpha
0.2194
(0.17)
0.0953
(0.05)
N/A
(0.27)
0.1665
(0.03)
(0.36)
Total Risk Alpha
(0.14)
(0.43)
(0.57)
(0.27)
N/A
(0.76)
(0.14)
(0.36)
(0.68)
Sortino Ratio
0.0575
(0.03)
0.0108
N/A
N/A
N/A
0.0519
N/A
N/A
Downside Variance
5.29
7.11
30.74
N/A
N/A
N/A
4.76
N/A
N/A
Standard Deviation
2.42
2.99
4.77
1.49
N/A
2.57
2.28
2.13
2.49
Kurtosis
(0.26)
2.29
2.21
0.7181
N/A
22.42
6.35
5.28
3.17
Potential Upside
4.67
4.98
9.09
2.56
N/A
2.61
3.07
2.76
3.42
Treynor Ratio
3.91
0.0117
0.2467
(0.42)
N/A
0.3686
0.4858
0.4909
(0.43)
Maximum Drawdown
10.83
17.75
27.01
8.37
N/A
18.68
17.08
10.43
16.7
Variance
5.83
8.91
22.71
2.23
N/A
6.63
5.18
4.55
6.2
Market Risk Adjusted Performance
3.92
0.0217
0.2567
(0.41)
N/A
0.3786
0.4958
0.5009
(0.42)
Risk Adjusted Performance
0.0664
0.0151
0.0294
(0.01)
N/A
(0.08)
0.0648
2.0E-4
(0.06)
Skewness
0.4211
0.4667
(0.13)
0.5215
N/A
(3.70)
0.8912
(0.07)
(0.04)
Semi Deviation
1.86
2.62
3.86
N/A
N/A
N/A
1.79
N/A
N/A
Information Ratio
0.0547
(0.02)
0.0126
(0.09)
N/A
(0.18)
0.0497
(0.06)
(0.16)
Value At Risk
(3.39)
(3.95)
(5.88)
(2.38)
N/A
(3.49)
(2.76)
(2.90)
(4.35)
Expected Short fall
(2.50)
(2.32)
(5.59)
N/A
N/A
N/A
(1.99)
N/A
N/A
Downside Deviation
2.3
2.67
5.54
N/A
N/A
N/A
2.18
N/A
N/A
Semi Variance
3.47
6.87
14.86
N/A
N/A
N/A
3.21
N/A
N/A

BARRY CALLEBA Competition Performance Charts

Five steps to successful analysis of BARRY CALLEBA Competition

BARRY CALLEBA's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by BARRY CALLEBA ADR in relation to its competition. BARRY CALLEBA's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of BARRY CALLEBA in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact BARRY CALLEBA's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to BARRY CALLEBA ADR, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your BARRY CALLEBA position

In addition to having BARRY CALLEBA in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Drugs Thematic Idea Now

Drugs
Drugs Theme
Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. The Drugs theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Drugs Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in BARRY Stock

BARRY CALLEBA financial ratios help investors to determine whether BARRY Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BARRY with respect to the benefits of owning BARRY CALLEBA security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY